5 Outrageous Info Regarding Cyclopamine Told By Professional

Mouse care and use was performed in accordance with local ethical guidelines. All the data from quantitative assays were expressed as the mean �� SD. Statistical analyses were performed using the independent-samples t test or one-way ANOVA. The difference was considered statistically significant when p http://www.selleckchem.com/products/BI-2536.html obtained from ovarian cancer cell line and stage III serous adenocarcinomas patients based on these four properties. We found that a typical spheroid contained more than 100 viable http://www.selleckchem.com/products/Cyclopamine.html cells. These oligo-clones of cells have been serially passaged for many generations without any visible sign of senescence, for at least 18 months to date (Supporting Information Fig. 1A). Our findings are consistent with previous results from Lee et al. [16], in which they used the same selection method to enrich CSCs and demonstrated that prolonged in vitro passages are the product of an outgrowth of a cell clone(s). Accumulating evidence indicates that CD133 is a key molecular marker to identify many types of CSLC, including ovarian CSLCs [2, 4, 20, 21]; thus we assessed the percentage of CD133+ cells after serum-free selection using FACS analysis and immunostaining. We found that less than 5% of cells expressed CD133 before serum-free culture selection, however, the proportion of CD133+ cells gradually increased with passage generation. After the fourth passage, more than 90% of the spheroid cells, which are suitable for the anchorage-independent growth, were positive for CD133 (Supporting Information Fig. 1B, 1D). In addition to CD133, it has been demonstrated that CSLCs express http://www.selleck.cn/products/gsk126.html other stem cell markers, including Oct-4 and Nanog [5, 22]. RT-PCR analysis showed that our CD133+ spheres expressed high levels of CSC markers, such as Oct-4 and Nanog, while spheres cultured under differentiating conditions showed minimal expression of stem cell markers (Supporting Information Fig. 1C). To investigate the differentiation capacity of CSLCs, we performed a standard differentiation assay and found that spheroid cells adhered to plates and acquired an epithelial morphology similar to the A2780 cancer cells. These cells expressed the ovarian cancer epithelial markers CA125 after culture in differentiating conditions for 11 days (Supporting Information Fig. 1E). Additionally, in vivo xenograft experiments, we found that the injection of CD133+ CSLCs, as few as 103 per mouse, was able to consistently generate tumor xenografts; in the same moue, 105 CD133? cells was far less tumorigenic (Supporting Information Fig. 1F; Supporting Information Table 2).